Brighthouse Financial, Inc.
—- Market cap
- $3.08B
- Debt
- +$3.16B
- Cash
- —
Complete market value, debt and cash evidence is required for enterprise value.
Capital structure 49% equity / 51% debt
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: BHF stock price vs ANIK: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at ANIK's multiple
Needs ANIK P/E.
Implied fair value · at BHF's multiple
Needs EPS (TTM) is negative, BHF P/E.
Snapshot Sep 4, 4:00 PM ET
Metric by metric
Where each company leads, and how wide the gap is.
Growth edge
Pricing power
Operating leverage
Multiple discount
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: BHF FY 2025 (ended Dec 31, 2025) · ANIK FY 2025 (ended Dec 31, 2025).
Trendline
Five fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Complete market value, debt and cash evidence is required for enterprise value.
Capital structure 49% equity / 51% debt
Capital structure 100% equity / -0% debt · EV / Revenue 1.75x
BHF carries the larger enterprise value at $6.24B against $197.18M; BHF trades on the lower EV / Revenue multiple (0.92x vs 1.75x).
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
Brighthouse Financial, Inc. · implied price per share
Five annual free-cash-flow observations are required for the filing-backed baseline.
Anika Therapeutics, Inc. · implied price per share
At least 3 of the last 5 annual free-cash-flow observations must be positive.
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Debt / equity
Total debt against shareholders' equity
0.47x
-0.00x
Net debt / EBITDA
Leverage against operating earnings
—
34.65x
Cash and equivalents
Liquid reserves on the balance sheet
—
$81.17M
Total debt
Interest-bearing obligations outstanding
$3.16B
-$149.00K
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
LINCOLN NATIONAL CORP
BHF vs LNC
Jackson Financial Inc.
BHF vs JXN
METLIFE INC
BHF vs MET
PRINCIPAL FINANCIAL GROUP INC
BHF vs PFG
PRUDENTIAL FINANCIAL INC
BHF vs PRU
ZIMMER BIOMET HOLDINGS, INC.
BHF vs ZBH
STRYKER CORP
BHF vs SYK
BECTON DICKINSON & CO
BHF vs BDX
INTEGRA LIFESCIENCES HOLDINGS CORP
BHF vs IART
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.